BioMAS Ltd: Clinical Trials

6 trials sponsored by BioMAS Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed, 1 suspended, 1 unknown. 6 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Terminated 2, Completed 1, Suspended 1, Unknown 1, Withdrawn 1
Phase 11Completed 1

Follow BioMAS Ltd: new trials by email

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients
AS101 - Acute Myeloid Leukemia, Myelodysplastic Syndrome
Phase 2SuspendedBioMAS Ltd122015-01-012015-02-10
Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts
15% AS101 gel, Vehicle - External Genital Warts
Phase 2UnknownBioMAS Ltd602015-01-012016-11-01
Safety and Efficacy Study to Test Topical AS101 for External Genital Warts
Topical AS101 - Wart; External Genital Organs, Condyloma Acuminata
Phase 1 / Phase 2CompletedBioMAS Ltd122012-03-012013-08-15
Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients
AS101 - Chemotherapy Induced Thrombocytopenia
Phase 2TerminatedBioMAS Ltd402009-08-012011-06-21
Topical Application of AS101 for the Treatment of Atopic Dermatitis
AS101 ointment - Atopic Dermatitis
Phase 2TerminatedBioMAS Ltd52009-06-012014-07-17
Topical Application of AS101 for the Treatment of Psoriasis
AS101 Cream - Mild to Moderate Psoriasis
Phase 2WithdrawnBioMAS Ltd2008-11-012015-07-23

Conditions studied

Dermatitis, Atopic (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Myelodysplastic Syndromes (1)  ·  Warts (1)

Interventions

ammonium trichloro(dioxoethylene-O,O'-)tellurate (3)

Countries

Israel (6)

Top investigators

Shabtai Romano, MD (2)  ·  Arie Ingbar, Prof (1)  ·  Baruch Klein, Prof (1)  ·  Felix Pavlotsky, MD (1)